DE68901153D1 - DERIVATIVES OF PURIN, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATION. - Google Patents

DERIVATIVES OF PURIN, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATION.

Info

Publication number
DE68901153D1
DE68901153D1 DE8989850146T DE68901153T DE68901153D1 DE 68901153 D1 DE68901153 D1 DE 68901153D1 DE 8989850146 T DE8989850146 T DE 8989850146T DE 68901153 T DE68901153 T DE 68901153T DE 68901153 D1 DE68901153 D1 DE 68901153D1
Authority
DE
Germany
Prior art keywords
hydroxy
amino
hydrogen
compounds
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989850146T
Other languages
German (de)
Inventor
Bjoern Gunnar Lindborg
Roelf Datema
Karl Nils Gunnar Johansson
Bo Fredrik Oeberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medivir AB
Original Assignee
Medivir AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir AB filed Critical Medivir AB
Application granted granted Critical
Publication of DE68901153D1 publication Critical patent/DE68901153D1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Antivirally active compounds of the formula <CHEM> wherein: R<1> is hydrogen, hydroxy, mercapto or amino; R<2> is hydrogen, hydroxy, fluoro, chloro or amino; R<3> and R<4> are independently selected from - @(OM)2, <CHEM> amino, hydroxy or an ether or ester residue thereof, or R<3> together with R<4> is <CHEM> wherein M is hydrogen or a pharmaceutically acceptable counterion; and n is 1 or 2; with the proviso that, when R<2> is amino and R<3> and R<4> are hydroxy, R<1> is not hydroxy and in addition, when n = 1, R<1> is not hydrogen, and pharmaceutically acceptable salts thereof; processes and preparation of said compounds, a pharmaceutical composition comprising said compounds, methods for treatment of virus infections as well as use of compounds of the formula I without the proviso for the manufacture of a medicament for treatment of AIDS.
DE8989850146T 1988-05-06 1989-05-05 DERIVATIVES OF PURIN, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATION. Expired - Fee Related DE68901153D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8801729A SE8801729D0 (en) 1988-05-06 1988-05-06 PURINE DERIVATIVES FOR USE IN THERAPY

Publications (1)

Publication Number Publication Date
DE68901153D1 true DE68901153D1 (en) 1992-05-14

Family

ID=20372263

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989850146T Expired - Fee Related DE68901153D1 (en) 1988-05-06 1989-05-05 DERIVATIVES OF PURIN, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATION.

Country Status (18)

Country Link
EP (1) EP0343133B1 (en)
JP (1) JP2866688B2 (en)
KR (1) KR0141913B1 (en)
AT (1) ATE74603T1 (en)
CA (1) CA1340909C (en)
DE (1) DE68901153D1 (en)
DK (1) DK174986B1 (en)
ES (1) ES2033548T3 (en)
FI (1) FI98729C (en)
GR (1) GR3004482T3 (en)
HU (1) HU207082B (en)
IE (1) IE62066B1 (en)
IL (1) IL90166A (en)
MY (1) MY108541A (en)
NZ (1) NZ229002A (en)
PT (1) PT90478B (en)
SE (1) SE8801729D0 (en)
WO (1) WO1989010923A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
US5728575A (en) * 1990-02-01 1998-03-17 Emory University Method of resolution of 1,3-oxathiolane nucleoside enantiomers
US5356886A (en) * 1990-07-19 1994-10-18 Beecham Group P.L.C. Antiviral phosphono-alken derivatives of purines
GB9020932D0 (en) * 1990-09-26 1990-11-07 Wellcome Found Heterocyclic compounds
US5208221A (en) * 1990-11-29 1993-05-04 Bristol-Myers Squibb Company Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
US5334525A (en) * 1992-08-28 1994-08-02 Fox Chase Cancer Center Hepadnavirus polymerase gene product having RNA-dependent DNA priming and reverse transcriptase activities and methods of measuring the activities thereof
US5360714A (en) * 1992-08-28 1994-11-01 Fox Chase Cancer Center Hepadnavirus polymerase gene product having RNA-dependent DNA priming and reverse transcriptase activities and methods of measuring the activities thereof
US5798340A (en) 1993-09-17 1998-08-25 Gilead Sciences, Inc. Nucleotide analogs
US5656745A (en) * 1993-09-17 1997-08-12 Gilead Sciences, Inc. Nucleotide analogs
JPH09506333A (en) * 1993-09-17 1997-06-24 ギリアード サイエンシーズ，インコーポレイテッド Method of administering therapeutic compound
DE19540798A1 (en) * 1995-11-02 1997-05-07 Hoechst Ag Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as medicines
US20030040467A1 (en) 1998-06-15 2003-02-27 Mary Ann Pelleymounter Ig/ob fusions and uses thereof.
US5717095A (en) * 1995-12-29 1998-02-10 Gilead Sciences, Inc. Nucleotide analogs
CA2239020A1 (en) * 1995-12-29 1997-07-10 Norbert W. Bischofberger Nucleotide analogs
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US6184376B1 (en) 1997-02-10 2001-02-06 Mediver Ab Synthesis of acyclic nucleoside derivatives
CA2277151C (en) * 1997-02-10 2007-04-17 Medivir Ab Synthesis of acyclic nucleoside derivatives
JP2009298785A (en) * 1997-02-10 2009-12-24 Medivir Ab Synthesis of acyclic nucleoside derivative
US6753322B2 (en) 2000-06-06 2004-06-22 Pfizer Inc 2-aminocarbonyl-9H-purine derivatives
JP4397691B2 (en) 2001-10-30 2010-01-13 コンフォーマ・セラピューティクス・コーポレイション Purine analogs having HSP90 inhibitory activity
TWI332507B (en) 2002-11-19 2010-11-01 Hoffmann La Roche Antiviral nucleoside derivatives
US7138401B2 (en) 2003-09-18 2006-11-21 Conforma Therapeutics Corporation 2-aminopurine analogs having HSP90-inhibiting activity
JP2008534609A (en) 2005-03-30 2008-08-28 コンフォーマ・セラピューティクス・コーポレイション Alkynylpyrrolopyrimidines and related analogs as HSP90 inhibitors
EP2326619B1 (en) 2008-08-01 2019-02-27 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same
CN102250126A (en) * 2010-05-18 2011-11-23 北京化工大学 Dipurine derivative and synthesis thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890001487B1 (en) * 1982-10-14 1989-05-04 더 웰컴 파운데이숀 리미티드 Process for the preparation of purine derivatives
CS233665B1 (en) * 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
SE8406538D0 (en) * 1984-12-21 1984-12-21 Astra Laekemedel Ab NOVEL DERIVATIVES OF PURINE
MY101126A (en) * 1985-12-13 1991-07-31 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
JP2866688B2 (en) 1999-03-08
HU893004D0 (en) 1991-09-30
SE8801729D0 (en) 1988-05-06
HU207082B (en) 1993-03-01
DK264990D0 (en) 1990-11-05
EP0343133A1 (en) 1989-11-23
FI98729C (en) 1997-08-11
HUT57767A (en) 1991-12-30
ES2033548T3 (en) 1993-03-16
MY108541A (en) 1996-10-31
AU626300B2 (en) 1992-07-30
DK174986B1 (en) 2004-04-13
NZ229002A (en) 1997-05-26
FI905475A0 (en) 1990-11-05
IE62066B1 (en) 1994-12-14
ATE74603T1 (en) 1992-04-15
EP0343133B1 (en) 1992-04-08
PT90478B (en) 1994-08-31
PT90478A (en) 1989-11-30
IE891472L (en) 1989-11-06
GR3004482T3 (en) 1993-03-31
WO1989010923A1 (en) 1989-11-16
AU3572689A (en) 1989-11-29
IL90166A (en) 1996-09-12
DK264990A (en) 1990-11-05
IL90166A0 (en) 1989-12-15
JPH03504243A (en) 1991-09-19
KR0141913B1 (en) 1998-06-01
FI98729B (en) 1997-04-30
CA1340909C (en) 2000-02-22

Similar Documents

Publication Publication Date Title
DE68901153D1 (en) DERIVATIVES OF PURIN, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATION.
EP0371731A3 (en) Quinazolinone derivatives
DE68919010D1 (en) Purine compounds, processes for their preparation and pharmaceutical preparations.
DK0539204T3 (en) Antiviral 4-substituted-deoxy-2,3-didehydro derivatives of alpha-D-neuraminic acid
EE02995B1 (en) Use of 1,3-oxathiolane nucleoside analogues for the preparation of hepatitis B drugs
NO166448C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIAZOLIDE INDIANS.
NL950022I2 (en) Analogues of mevalolactone and derivatives thereof, methods of their preparation, pharmaceutical preparations containing them and their use as pharmaceuticals.
DE69110625D1 (en) Oxazolopyridine derivatives, processes for their preparation and the pharmaceutical compositions containing them.
ES2123039T3 (en) NEW 3- (HYDROXY-BENCILIDENIL) -INDOLIN-2-ONAS, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ZA936658B (en) Benzopyran compounds process for their preparation and the pharmaceutical compositions which contain them
ES2051834T3 (en) THE USE OF TETRAHYDROBENZENE (C, D) INDOL-6 CARBOXAMIDES FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF ANXIETY.
PT80191B (en) Process for preparing substituted benzopyrans useful as medicaments
ES2111352T3 (en) USE OF DIESTER PHOSPHATE FOR THE TREATMENT OF RETINAL DISEASES.
DK408083A (en) ISOQUINOLINE DERIVATIVES, THEIR PREPARATION AND USE
ES480112A1 (en) Derivatives of 2-imino-imidazolidine, processes for their preparation, pharmaceutical compositions containing them and intermediates.
ATE41659T1 (en) BENZOTHIAZEPINE DERIVATIVES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS.
ATE161011T1 (en) NEW CARBOXIC ACID ESTERS OF 2-AMINO-7-(1,3-DIHYDROXY-2-PROPOXYMETHYL)PURINE, THEIR PRODUCTION AND USE
ES2095714T3 (en) NEW AMINO-ALKYL-CHROME, ITS PREPARATION PROCEDURES AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ZA933942B (en) Pyrrolothienopyrazine compounds, processes for the preparation thereof and pharmaceutical compositions containing them
IT1245390B (en) Pharmaceutical composition with antiviral activity
FR2592653A1 (en) Chromene derivatives, process of preparation and pharmaceutical compositions

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee